Previous Article | Next Article ![]()
Infection and Immunity, October 2001, p. 6554-6557, Vol. 69, No. 10
Medical Research Council Laboratories,
Fajara,1 and National Tuberculosis
Control Programme, Banjul,4 The
Gambia; Université Libre de Bruxelles, Brussels,
Belgium2; London School of Hygiene and
Tropical Medicine, London, United Kingdom3;
and Statens Serum Institut, Copenhagen,
Denmark5
Received 8 December 2000/Returned for modification 22 January
2001/Accepted 9 July 2001
The Mycobacterium tuberculosis antigen ESAT-6 has
been proposed for tuberculosis immunodiagnosis. In The Gambia, 30% of
community controls produced gamma interferon (IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.10.6554-6557.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Tuberculosis Contacts but Not Patients Have Higher Gamma
Interferon Responses to ESAT-6 than Do Community Controls in
The Gambia
) in response to
ESAT-6. Increased proportions of responders and intensities of
responses were found in household contacts. Responses that were
initially low in tuberculosis patients increased after treatment. An
ESAT-6 IFN-
assay will be of limited use in the diagnosis of
tuberculosis in countries where tuberculosis is endemic. Its role in
contact tracing should be evaluated further.
*
Corresponding author. Mailing address: Laboratoire
d'Immunologie Expérimentale, Bâtiment GE,
Faculté de Médecine, 808 Route de Lennik, 1070 Brussels,
Belgium. Phone: 220 495 442. Fax: 32 2 675 7878. E-mail:
Johan.Vekemans{at}ulb.ac.be.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|